How does Loqtorzi work for nasopharyngeal carcinoma?

Drugs.com

Official answer

by Drugs.com

Loqtorzi (toripalimab) is a new investigational treatment that is not yet FDA-approved but may be available through a clinical trial for people with advanced nasopharyngeal carcinoma (NPC). Loqtorzi boosts our immune system and works by binding to a receptor called Programmed cell death protein 1 (PD-1) that exists on the outside of some cancer cells.

PD-1 prevents our immune system from attacking the cancerous cells, but once Loqtorzi has bound to PD-1, the immune system is no longer inhibited, and immune system components, such as T cells, can kill the cell. Loqtorzi is also thought to lower the number of PD-1 receptors on the outside of the cancer cells by causing the PD-1 receptor to be absorbed inside the cancer cells.

Loqtorzi is an anti-PD-1 monoclonal antibody that belongs to the class of medicines called Checkpoint inhibitors and is given by intravenous infusion.

Is Loqtorzi chemotherapy?

Loqtorzi works with the immune system to help fight cancer and is considered an immunotherapy treatment, not chemotherapy.

Related medical questions

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords